RS Oncology’s development pipeline was initiated in early 2022 with the phase 1/2 MITOPE clinical trial
Local intrapleural administration via a catheter
Malignant Pleural Mesothelioma
Malignant Disease to the Lungs
Pleural Effusion
Systemic Treatment
TBD
